New data from the CDC show startling declines in mental health; Biden recommends public mask-wearing for 3 months; FDA issues new warning on hand sanitizers.
New CDC data show that during June 24 to 30, 2020, 40% of adults in the United States reported considerably elevated adverse mental health conditions associated with coronavirus disease 2019 (COVID-19). In particular, young adults, racial and ethnic minorities, essential workers, and unpaid adult caregivers reported disproportionately worse mental health outcomes, increased substance use, and elevated suicidal ideation during this time. Compared with the 30 days prior to the survey, anxiety and depression symptoms increased by 31%, trauma and stressor-related disorder symptoms increased by 26%, 11% seriously considered suicide, and 13% started or increased their substance use.
The presumptive Democratic presidential nominee, Joe Biden, is calling for each governor in the United States to mandate their citizens wear a mask when they’re outside for the next 3 months, NPR reports. During a joint appearance with his newly announced running mate, Senator Kamala Harris (D-CA), Biden said the measure is estimated to save more than 40,000 lives in the coming months. Currently, more than 165,000 Americans have died from COVID-19, as states and regions throughout the country implement varying degrees of mask mandates. Should he be elected president in November, Biden said he would use the power of the executive branch to make mask-wearing a public requirement.
The FDA has updated its list of hand sanitizers the public should not use due to the presence of toxic chemicals in some formulas, The Hill reports. The agency said it has seen a spike in the number of hand sanitizers labeled to contain ethanol but have in fact tested positive for methanol, which can be toxic when absorbed through the skin or ingested. The presence of 1-propanol, a deadly toxin which can depress the central nervous system, was also detected in some samples. Some symptoms of exposure to the toxin include confusion, decreased consciousness, and slowed pulse and breathing. Contaminated products produced in Mexico or China were added to an import alert in an effort to stop shipment into the United States.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More